ViroPharma Sets High Pricing For Cinryze, Unveils Promotional Plan
Analyst opinions mixed, ranging from increased sales projections to a prediction of HAE competition driving down the price of the orphan therapeutic.
Analyst opinions mixed, ranging from increased sales projections to a prediction of HAE competition driving down the price of the orphan therapeutic.